Medtronic director exchanges 182 shares for MiniMed

The reported post-transaction position was 9,977 Medtronic ordinary shares, including 19 shares acquired through dividend reinvestment since the previous report.

Rhea-AI Filing Summary

Kevin E. Lofton reported disposition transactions in this Form 4 filing. Medtronic plc (MDT) director Kevin E. Lofton had 182 ordinary shares accepted for exchange in Medtronic’s MiniMed exchange offer on October 15, 2026. He received 836 MiniMed common shares at a final exchange ratio of 4.5939 MiniMed shares for each Medtronic share. His reported Medtronic holdings after the transaction were 9,977 ordinary shares, including 19 shares acquired through dividend reinvestment since his last report.

Insider Trade Summary

Other: 182 shares

Other 1 txn

Insider Lofton Kevin E

Role Director

Type	Security	Shares	Price	Value
Other	Ordinary Shares F1, F2	182	--	--

Holdings After Transaction: Ordinary Shares — 9,977 shares (Direct)

Footnotes (2)

1. F1. On October 15, 2026, 182 Medtronic plc ("Medtronic") ordinary shares beneficially owned by the Reporting Person were accepted for exchange in Medtronic's exchange offer for shares of common stock of MiniMed Group, Inc. ("MiniMed"). Pursuant to the exchange offer, the Reporting Person received 836 shares of MiniMed common stock based on the final exchange ratio of 4.5939 shares of MiniMed common stock for each Medtronic ordinary share accepted.
2. F2. Includes 19 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Key Figures

Medtronic ordinary shares accepted for exchange: 182 shares MiniMed common shares received: 836 shares Final exchange ratio: 4.5939 MiniMed common shares per Medtronic ordinary share +2 more

5 metrics

Medtronic ordinary shares accepted for exchange 182 shares October 15, 2026

MiniMed common shares received 836 shares October 15, 2026

Final exchange ratio 4.5939 MiniMed common shares per Medtronic ordinary share Medtronic exchange offer

Medtronic ordinary shares following transaction 9,977 shares Reported after the October 15, 2026 transaction

Shares acquired through dividend reinvestment 19 shares Since the reporting person’s last report

Key Terms

exchange offer, final exchange ratio, dividend reinvestment

3 terms

exchange offer financial

"Medtronic's exchange offer for shares of common stock of MiniMed Group, Inc."

An exchange offer is a proposal where a company asks investors to swap existing securities, like bonds or shares, for new ones, often with different terms or maturity dates. It matters to investors because it can affect the value of their holdings and the company's financial strategy, potentially providing benefits like better interest rates or reduced debt.

final exchange ratio financial

"based on the final exchange ratio of 4.5939 shares"

dividend reinvestment financial

"acquired through dividend reinvestment since the last report"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MDT shares did Kevin E. Lofton exchange, and what did he receive?

On October 15, 2026, 182 Medtronic ordinary shares held by Kevin E. Lofton were accepted for exchange, and he received 836 MiniMed common shares at a final exchange ratio of 4.5939 MiniMed shares for each Medtronic share.

How many MDT shares did Kevin E. Lofton hold after the exchange?

His reported post-transaction position was 9,977 Medtronic ordinary shares. The total includes 19 shares acquired through dividend reinvestment since his last report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/21/2026 - 05:18 PM EDT Accepted by SEC EDGAR 10/21/2026 - 05:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lofton Kevin E

(Last) (First) (Middle)

C/O MEDTRONIC

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/15/2026		J(1)		182	D	(1)	9,977(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 15, 2026, 182 Medtronic plc ("Medtronic") ordinary shares beneficially owned by the Reporting Person were accepted for exchange in Medtronic's exchange offer for shares of common stock of MiniMed Group, Inc. ("MiniMed"). Pursuant to the exchange offer, the Reporting Person received 836 shares of MiniMed common stock based on the final exchange ratio of 4.5939 shares of MiniMed common stock for each Medtronic ordinary share accepted.

2. Includes 19 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	10/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)